Consensus Abbott Laboratories

Stocks

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 04:03:25 2026-10-28 pm EDT			5-day change	1st Jan Change
102.64 ^USD	-0.45%		+2.12%	-18.08%

Oct. 28	German startup NVision shows new path to quantum computing chips in Nature paper	RE
Oct. 28	German startup NVision shows new path to quantum computing chips in Nature paper	RE

Evolution of the Average Target: Abbott Laboratories

Evolution of the Target Price: Abbott Laboratories

Changes in Analyst Recommendations: Abbott Laboratories

535e929d08.6doQswnw0e_hEIxl_LeZaaCzDfy0d_g_4pJKqPfOM74.xOpy5kXDtqqEXOoRiM7PB_GCXIzeG7J42tcD4rGCfe-lhVrxa4G2sIslzQ~2155e5316ad86467a18332f0cc2c14c1

Analysts' recommendations: Abbott Laboratories

Oct. 27	Abbott Laboratories Shares Fall After Argus Downgrade	MT
Oct. 27	Argus Downgrades Abbott Laboratories to Hold From Buy	MT
Oct. 22	Abbott Laboratories' 2026 Guidance Cut Driven by Diabetes, Electrophysiology Portfolio, RBC Says	MT
Oct. 22	Jefferies & Co Adjusts Abbott Laboratories Price Target to $130 From $135	MT
Oct. 22	RBC Trims Price Target on Abbott Laboratories to $125 From $130, Keeps Outperform Rating	MT
Oct. 22	Leerink Partners Adjusts Price Target on Abbott Laboratories to $106 From $109	MT
Oct. 22	BTIG Adjusts Price Target on Abbott Laboratories to $125 From $134	MT
Oct. 22	Wells Fargo Adjusts Price Target on Abbott Laboratories to $119 From $112	MT
Oct. 22	JPMorgan Adjusts Price Target on Abbott Laboratories to $118 From $120	MT
Oct. 22	TD Cowen Adjusts Price Target on Abbott Laboratories to $118 From $135	MT
Oct. 20	Abbott Laboratories' Established Pharma Unit Undervalued on Biosimilars Potential, UBS Says	MT
Oct. 07	Barclays Initiates Coverage on Abbott Laboratories With Overweight Rating, $120 Price Target	MT
Oct. 05	Evercore ISI Adjusts Price Target on Abbott Laboratories to $124 From $120, Keeps Outperform Rating	MT
Oct. 02	Rothschild & Co Redburn Upgrades Abbott Laboratories to Buy From Neutral, Adjusts PT to $127 From $119	MT
Oct. 02	Rothschild & Co Redburn Upgrades Abbott Laboratories to Buy From Neutral, Adjusts PT to $127 From $119	MT
Oct. 02	Analyst recommendations: Airbnb, Hewlett Packard Enterprise, Fair Isaac, Nike…
Aug. 21	TD Cowen Adjusts Price Target on Abbott Laboratories to $135 From $115, Maintains Buy Rating	MT
Aug. 13	Citigroup Adjusts Price Target on Abbott Laboratories to $125 From $112, Maintains Buy Rating	MT
Aug. 13	Wolfe Research Upgrades Abbott Laboratories to Outperform From Peer Perform, PT is $130	MT
Jul. 28	UBS Adjusts Price Target on Abbott Laboratories to $125 From $135, Maintains Buy Rating	MT
Jul. 28	Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating	MT
Jul. 23	Daiwa Securities Adjusts Price Target on Abbott Laboratories to $103 From $92, Maintains Neutral Rating	MT
Jul. 22	Leerink Partners Adjusts Price Target on Abbott Laboratories to $109 From $106, Maintains Market Perform Rating	MT
Jul. 17	Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says	MT
Jul. 17	JPMorgan Adjusts Price Target on Abbott Laboratories to $120 From $110, Maintains Overweight Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+14.96%
	STRYKER CORPORATION					+20.3%
	MEDTRONIC PLC					+11.35%
	ESSILORLUXOTTICA					+18.76%
	CENCORA, INC.					+13.44%
	HOYA CORPORATION					+16.14%
	BECTON, DICKINSON AND COMPANY					+0.28%
	IDEXX LABORATORIES, INC.					+23.73%
	ALCON INC.					+30.6%
	DEXCOM, INC.					+22.44%
	Average					+17.20%
	Weighted average by Cap.					+16.09%